Cardlytics Carries On Revenue Contraction In The Middle Of Deteriorating Business Economics (NASDAQ: CDLX)

.Financial article writer advises selling Cardlytics, Inc. because of dropping unit business economics, profits obstacles, and unfavorable financial fads. Click on for this CDLX upgrade.